共 65 条
[1]
Burkhardt B(2016)Current status and future directions of T-lymphoblastic lymphoma in children and adolescents Br J Haematol 173 545-559
[2]
Mueller S(2017)Lymphoblastic lymphoma Crit Rev Oncol Hematol 113 304-317
[3]
Khanam T(2017)Adult T-type lymphoblastic lymphoma: treatment advances and prognostic indicators Exp Hematol 51 7-16
[4]
Cortelazzo S(2020)Chidamide in combination with chemotherapy in refractory and relapsed T lymphoblastic lymphoma/leukemia Leuk Lymphoma 61 855-861
[5]
Ferreri A(2018)PET/CT for staging; past, present, and future Semin Nucl Med 48 4-16
[6]
Hoelzer D(2019)Early evaluation of tumor response to 90Y-ibritumomab radioimmunotherapy in relapsed/refractory B cell non-Hodgkin lymphoma: what is the optimal timing for FDG-PET/CT? Eur Radiol 29 3935-3944
[7]
Lepretre S(2020)Performance of CT compared with 18F-FDG PET in predicting the efficacy of nivolumab in relapsed or refractory hodgkin lymphoma Radiology 295 651-661
[8]
Graux C(2020)Baseline Eur Radiol 30 4623-4632
[9]
Touzart A(2017)F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy Oncotarget 8 99104-99111
[10]
Guan W(2020)Interim PET-CT may predict PFS and OS in T-ALL/LBL adult patients Am J Hematol. 95 1466-72